Sentences with phrase «generation vaccine company»
Immune Design is a new generation vaccine company built on emerging understanding of the role of dendritic cells in determining an effective immune response.
http://www.thecolumngroup.com/ Not exact matches
In October he started a new company that will work with the pharmaceutical giant Novartis to create next - generation flu vaccines.
An expert jury says that the company's research could lead to a new generation of vaccines that don't need refrigeration — a massive benefit in many poor countries where power and equipment are in short supply.
In November 2012, the company also showed, along with scientists from the Friedrich Loeffler Institute, that the technology could lead to a new generation of flu vaccines.
The countries pledged the monies to create what amounts to an artificial market for the vaccines to provide incentive for pharmaceutical companies to introduce next - generation pneumococcal injections more rapidly, which could then be shipped to impoverished countries.
CAMBRIDGE, Mass., April 27, 2017 — Moderna Therapeutics, a clinical stage biotechnology company that is pioneering messenger RNA (mRNA) Therapeutics ™ to create a new generation of transformative medicines for patients, today announced positive interim data from an ongoing Phase 1 study of mRNA - 1440, an mRNA infectious disease vaccine against avian H10N8 influenza, demonstrating mRNA - 1440 induced high levels of immunogenicity, and was safe and well tolerated.
CAMBRIDGE, Mass., July 13, 2017 — Moderna Therapeutics, a clinical stage biotechnology company that is pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, today announced new data demonstrating that its Zika mRNA vaccine prevented Zika virus transmission from pregnant mice to their fetuses.
Synthetic Genomics (SGI) and the J. Craig Venter Institute (JCVI) have formed a new company, Synthetic Genomics Vaccines (SGVI), to develop next - generation vaccines based on synthetic genome tecVaccines (SGVI), to develop next - generation vaccines based on synthetic genome tecvaccines based on synthetic genome technology.
By bringing together for the first time three of Europe's leading vaccine development and manufacture companies as well as top experts from academic institutions and small and medium - sized enterprises (SMEs), the project will ultimately accelerate the development and introduction of a new generation of safer, more effective vaccines.